Table 2.
Pre-procedural Health Care Utilization of California Patients Receiving Medicaid-Funded Long-Acting Contraceptive Procedures, 2008–2014
| Levonorgestrel IUC (n = 35,705) | Copper IUC (n = 23,628) | Tubal ligation (n = 23,965) | |
|---|---|---|---|
| Obesity (BMI ≥ 30 kg/m2) | 9.14 | 8.77 | 11.70 |
| Any pregnancy | 70.94 | 74.95 | 57.65 |
| C-section | 18.40 | 20.56 | 10.85 |
| Ectopic pregnancy | 1.31 | 1.60 | 1.71 |
| Any contraceptive use | 51.51 | 52.51 | 49.10 |
| Fibroids | 1.72 | 0.94 | 6.53 |
| Mood | 11.32 | 9.84 | 16.21 |
| Pelvic pain | 15.32 | 14.66 | 35.25 |
| Pelvic inflammatory disease (PID) | 1.49 | 1.45 | 4.56 |
| Menorrhagia | 28.66 | 28.67 | 33.82 |
| Abdominal pain and gastrointestinal symptoms | 31.69 | 30.82 | 42.51 |
| Genitourinary pain | 4.46 | 4.08 | 6.25 |
| Non-abdominal pain | 30.71 | 29.65 | 41.11 |
| Charlson Comorbidity Index | 0.22 ± 0.62 | 0.22 ± 0.65 | 0.37 ± 0.80 |
| Months of Medi-Cal enrollment in 2 years prior to procedure | 18.00 ± 6.86 | 18.45 ± 6.64 | 19.20 ± 6.70 |
Excluding procedures performed within 42 days of a birth, through 8/31/2014. The percentage of patients with one or more claims related to various conditions in 2 years before their contraceptive procedure. P < 0.001 for all variables compared across the three contraceptive procedures. Data are mean ± standard deviation or percentages.
BMI body mass index